Jim C. Mullen

Chairman, President & Chief Executive Officer at Editas Medicine, Inc.

Jim C. Mullen

Jim C. Mullen

Chairman, President & Chief Executive Officer at Editas Medicine, Inc.

Overview

Career Highlights

Biogen Idec New Ventures, Inc.
Editas Medicine, Inc.
Patheon NV

RelSci Relationships

2977

Number of Boards

16

Birthday

1959

Age

62

Contact Data

Trying to get in touch with Jim C. Mullen? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!

Relationships

View Relationship Details

RelSci Relationships are individuals Jim C. Mullen likely has professional access to. A relationship does not necessarily indicate a personal connection.

Cecil B. Pickett

Former President, Research & Development at Biogen, Inc.

Relationship likelihood: Strong

Michel Vounatsos

Chief Executive Officer at Biogen, Inc.

Relationship likelihood: Strong

Hans-Peter Hasler

Founder at Vicarius Pharma AG

Relationship likelihood: Strong

James R. Tobin

Former President & Chief Executive Officer at Boston Scientific Corporation

Relationship likelihood: Strong

David R. Liu

Scientific Founder at Editas Medicine, Inc.

Relationship likelihood: Strong

George Church

Scientific Co-Founder at Inari Agriculture, Inc.

Relationship likelihood: Strong

Jessica Hopfield

Founder at J Hopfield Consulting

Relationship likelihood: Strong

J. Keith Joung

Scientific Founder at Editas Medicine, Inc.

Relationship likelihood: Strong

Feng Zhang

Scientific Founder at Editas Medicine, Inc.

Relationship likelihood: Strong

John Maraganore

Chief Executive Officer at Alnylam Pharmaceuticals, Inc.

Relationship likelihood: Strong

Reveal deeper insights into your organization's relationships
with RelSci Contact Aggregator.

Empower Your Business Applications with Industry-Leading
Relationship Data from the RelSci API.

Get Contact Information on the
World's Most Influential Decision Makers.

Discover the Power of Your Network with
RelSci Premium Products.

In The News

Nasdaq

February 26, 2021

Editas (EDIT) Misses on Q4 Earnings, Beats on Revenues

GlobeNewswire

February 25, 2021

Editas Medicine Announces Fourth Quarter and Full Year 2020 Results and Update

Nasdaq

February 23, 2021

Here's Why Editas Medicine Dropped Today

The Boston Globe

February 15, 2021

For Mullen, Editas CEO job 'too good to resist'

The Boston Globe

February 9, 2021

Former head of Biogen takes over as Editas CEO; James Mullen arrives as the Cambridge biotech prepares to test a sickle cell treatment

Paths to Jim C. Mullen

Potential Connections via
Relationship Science

You

Jim C. Mullen

Chairman, President & Chief Executive Officer at Editas Medicine, Inc.

Education

MBA

Class of 1984

Villanova University - Villanova School of Business

Villanova School of Business is a school in Villanova.

Bachelor of Science in Chemical Engineering

Class of 1980

Rensselaer Polytechnic Institute

Rensselaer Polytechnic Institute, or RPI, is a private research university located in Troy, New York, with two additional campuses in Hartford and Groton, Connecticut. It was founded in 1824 by Stephen van Rensselaer and Amos Eaton for the "application of science to the common purposes of life" and is the oldest technological university in the English-speaking world.

Career History

Chairman, President & Chief Executive Officer

2018 - Current

Editas Medicine, Inc.

Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA.

Chief Executive Officer & Executive Director

2011 - 2017

Patheon NV

Patheon NV engages in the provision of pharmaceutical development and manufacturing services. It focuses on drug development, clinical trial logistics, and commercial manufacturing. The company was founded on December 24, 2013 and is headquartered in Amsterdam, the Netherlands.

Chief Executive Officer

2011 - Prior

Patheon, Inc.

Patheon, Inc. provides drug development and manufacturing services to global pharmaceutical, biotechnology and specialty pharmaceutical companies. It operates through two segments: Commercial Manufacturing Outsourcing and Pharmaceutical Development Services. The Commercial Manufacturing Outsourcing segment manufactures prescription products in sterile dosage forms as well as solid and liquid conventional dosage forms. The Pharmaceutical Development Services segment provides a broad range of development services, including solid and sterile dosage forms. The company operates through four market segments: Biologics, Emerging Pharma, Generics and Large Pharma. Patheon was founded in 1974 and is headquartered in Mississauga, Canada.

Boards & Committees

Non-Executive Chairman

Current

Percivia LLC

Percivia LLC engages in the research and development of vaccine and recombinant protein products. The company was founded in 2006 and is headquartered in Cambridge, MA.

Independent Director

2004 - Prior

PerkinElmer, Inc.

As a global technology leader, PerkinElmer is taking action to harness the power of insights and transform them into knowledge to deliver innovative, differentiated solutions for our customers. From critical therapeutic and disease research and prenatal screening, to environmental testing and industrial monitoring, we are actively engaged in improving health and advancing quality and longevity of life all around the world. From multi-vendor laboratory services, software and informatics, to clinical lab testing and unparalleled customer care, we have the people, tools and resources to help customers solve their business and scientific goals. Our core competencies, coupled with our commitment to excellence, provide a strong foundation for delivering optimal service and support. By encouraging exploration, ingenuity and integrity, together with teamwork and employee development, at PerkinElmer we live our mission, every day

Member, Board of Directors

Current

Biomedical Sciences Careers Program, Inc.

The Biomedical Science Careers Program (BSCP) was founded in 1991 by Joan Y. Reede, M.D., M.P.H., M.S., M.B.A, with the aim of increasing the representation of underrepresented minority and disadvantaged individuals in all facets of science and medicine while helping health care institutions, biopharma/biotechnology firms, educational institutions, professional organizations and private industry members meet their need for a diverse workforce. BSCP was incorporated as a not-for-profit organization in 1994. The founding sponsors of BSCP are the Harvard Medical School Minority Faculty Development Program, the New England Board of Higher Education and the Massachusetts Medical Society.

Chairman, Board of Directors

Prior - 2007

Biotechnology Innovation Organization

Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers.

Political Donations

$500

2010

Charlie Baker

Governor at Massachusetts Office of the Governor, Charles Baker

$2,500

2010

Biotechnology Industry Organization Political Action Committee

$500

2006

Kerry Healey

President at Milken Institute - Center for Advancing the American Dream

Transactions

Details Hidden

Patheon, Inc. purchases Banner Pharmacaps, Inc. from Noordbrabantse Christelijke Boerenbond, Rooms-Katholieke

Investments

Details Hidden

Vicarius Pharma AG

Vicarius Pharma bridges the gap between traditional go-it-alone and out-licensing strategies by providing a low risk shared-value approach.they offer research-driven pharmaceutical, biotech and medical devices companies a platform of excellence from which we build a dedicated European commercial organization.

Public Holdings

Restricted data only for RelSci Professional users.

Other Affiliations

Jim C. Mullen is affiliated with Editas Medicine, Inc., Patheon NV, Patheon, Inc., Biogen Idec, Inc. (North Carolina), Biogen, Inc., Biogen Idec New Ventures, Inc., Biogen MA, Inc., Patheon Puerto Rico, Inc., DPI Newco LLC, DPx Holdings BV, GlaxoSmithKline LLC, Smithkline Beckman Corp., The Rivers School Corp., Percivia LLC, PerkinElmer, Inc., Biomedical Sciences Careers Program, Inc., Biotechnology Innovation Organization

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Jim C. Mullen. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Jim C. Mullen's profile does not indicate a business or promotional relationship of any kind between RelSci and Jim C. Mullen.